Matt Hoffman, associate editorial director for Contagion, has covered medical news for MJH Life Sciences, Contagion's parent company, since 2017. Follow him on Twitter @byMattHoffman or email him at mhoffman @neurologylive.com
FDA Places Clinical Hold on Novavax COVID-19-Influenza Combination Vaccine Due to Adverse Event
Novavax’s COVID-19-Influenza Combination vaccine faces a clinical hold after a trial participant developed motor neuropathy, pending further investigation by the FDA.